COMMON CO-ACTIVATION OF AXL AND CDCP1 IN EGFR-MUTATION-POSITIVE NON-SMALLCELL LUNG CANCER ASSOCIATED WITH POOR PROGNOSIS

Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis

Epidermal growth factor receptor (EGFR)-mutation-positive non-smallcell lung cancer (NSCLC) is incurable, despite high rates of response to EGFR tyrosine kinase inhibitors (TKIs).We investigated receptor tyrosine kinases (RTKs), Src family kinases and focal adhesion kinase (FAK) as genetic modifiers of innate resistance in EGFR-mutation-positive NS

read more